Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

10 Apr 2023

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. It is unclear how progression of NAFLD towards cirrhosis translates into systematic changes in circulating proteins. Here, we provide a detailed proteo-transcriptomic map of steatohepatitis and fibrosis during progressive NAFLD. In this multicentre proteomic study, we characterize...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lipid metabolism and disorders
Share to Liver Disease and Transplantation
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37037945
DOI: 10.1038/s42255-023-00775-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesPMID 37037945Read ↗

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severitySemantic proximity Read ↗

Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologiesSemantic proximity Read ↗

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.Semantic proximity Read ↗

MegaMASLD: An interactive platform for exploring stratified transcriptomic signatures in MASLD progressionSemantic proximity Read ↗

A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverSemantic proximity Read ↗

Integration of transcriptomic analysis and multiple machine learning approaches identifies NAFLD progression-specific hub genes to reveal distinct genomic patterns and actionable targetsSemantic proximity Read ↗

Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read ↗

SteatoSITE: an Integrated Gene-to-Outcome Data Commons for Precision Medicine Research in NAFLDSemantic proximity Read ↗

Unveiling the pathogenesis of non-alcoholic fatty liver disease by decoding biomarkers through integrated single-cell and single-nucleus profilesSemantic proximity Read ↗

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read ↗

Early Identification of At-Risk Patients: Proteomic Signature Predicts Progression to Decompensated CirrhosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.